Evidence map›Paper›PMID 9636148›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1998

Effective inhibition of influenza virus production in cultured cells by external guide sequences and ribonuclease P.

D Plehn-Dujowich, S Altman

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 89 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Effective inhibition of cytomegalovirus infection by external guide sequences in mice.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  16. Gene selective mRNA cleavage inhibits the development of Plasmodium falciparum.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

D Plehn-DujowichDepartment of Molecular, Cellular and Developmental Biology, Yale University, New Haven, CT 06520, USA.
S Altman
Yale University · US

Funding

PHS HHS 19422
6 · The paper itself

Abstract

The polymerase (PB2) and nucleocapsid (NP) genes encoded by the genome of influenza virus are essential for replication of the virus. When synthetic genes that express RNAs for external guide sequences targeted to the mRNAs of the PB2 and NP genes are stably incorporated into mouse cells in tissue culture, infection of these cells with influenza virus is nonproductive. Endogenous RNase P cleaves the targeted influenza virus mRNAs when they are in a complex with the external guide sequences. Targeting two different mRNAs simultaneously inhibits viral particle production more efficiently than does targeting only one mRNA.

Indexed as

NucleoproteinsVirus ReplicationAnimalsBase SequenceCell LineCells, CulturedCloning, MolecularEndoribonucleasesMiceMolecular Sequence DataNucleic Acid ConformationNucleocapsid ProteinsOrthomyxoviridaeRibonuclease PRNA, CatalyticRNA-Dependent RNA PolymeraseEndoribonucleasesNucleocapsid ProteinsNucleoproteinsPB2 protein, Influenzavirus ARibonuclease PRNA, CatalyticRNA-Dependent RNA PolymeraseRNA, MessengerRNA, Small UntranslatedViral Core ProteinsViral Proteins

Identifiers

PMID9636148
PMCPMC22606
OpenAlexW2035982269

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.